Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial.
Lancet Oncol. 2014 Jul;15(8):799-808. doi: 10.1016/S1470-2045(14)70244-X. Epub 2014 Jun 17.
Lancet Oncol. 2014.
PMID: 24950985
Clinical Trial.
Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.
Monk BJ, Poveda A, Vergote I, Raspagliesi F, Fujiwara K, Bae DS, Oaknin A, Ray-Coquard I, Provencher DM, Karlan BY, Lhommé C, Richardson G, Rincón DG, Coleman RL, Marth C, Brize A, Fabbro M, Redondo A, Bamias A, Ma H, Vogl FD, Bach BA, Oza AM.
Monk BJ, et al. Among authors: rincon dg.
Gynecol Oncol. 2016 Oct;143(1):27-34. doi: 10.1016/j.ygyno.2016.07.112. Epub 2016 Aug 18.
Gynecol Oncol. 2016.
PMID: 27546885
Clinical Trial.
Item in Clipboard
DNA Repair Proteins as Therapeutic Targets in Ovarian Cancer.
López-Camarillo C, Rincón DG, Ruiz-García E, Astudillo-de la Vega H, Marchat LA.
López-Camarillo C, et al. Among authors: rincon dg.
Curr Protein Pept Sci. 2019;20(4):316-323. doi: 10.2174/1389203719666180914091537.
Curr Protein Pept Sci. 2019.
PMID: 30215333
Review.
Item in Clipboard
Predictive factors for irresectability in advanced ovarian cancer.
Martínez-Saíd H, Rincón DG, Montes de Oca MM, Ruiz GC, Ponce JL, López-Graniel CM.
Martínez-Saíd H, et al. Among authors: rincon dg.
Int J Gynecol Cancer. 2004 May-Jun;14(3):423-30. doi: 10.1111/j.1048-891x.2004.014301.x.
Int J Gynecol Cancer. 2004.
PMID: 15228414
Item in Clipboard
Angiogenesis Analysis by In Vitro Coculture Assays in Transwell Chambers in Ovarian Cancer.
Flores-Pérez A, Rincón DG, Ruiz-García E, Echavarria R, Marchat LA, Álvarez-Sánchez E, López-Camarillo C.
Flores-Pérez A, et al. Among authors: rincon dg.
Methods Mol Biol. 2018;1699:179-186. doi: 10.1007/978-1-4939-7435-1_13.
Methods Mol Biol. 2018.
PMID: 29086377
Item in Clipboard
Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational era.
Creutzberg CL, Kitchener HC, Birrer MJ, Landoni F, Lu KH, Powell M, Aghajanian C, Edmondson R, Goodfellow PJ, Quinn M, Salvesen HB, Thomas G; GCIG Endometrial Cancer Clinical Trials Planning Meeting.
Creutzberg CL, et al.
Int J Gynecol Cancer. 2013 Oct;23(8):1528-34. doi: 10.1097/IGC.0b013e3182a26edb.
Int J Gynecol Cancer. 2013.
PMID: 24257568
Item in Clipboard
Cite
Cite